These analyses gave similar patterns as our own dataset for the presence of immune cells, such as dendritic cells, M1 and M2 subtypes of macrophages, CD8+ T cells, CD4+ T cells and naïve B cells in the melanoma tumour bed, which can discriminate between responders and non-responders to anti-PD1 therapy. Here, CD4 is linked to melanoma.